Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic?clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
This report aims to provide a comprehensive presentation of the global market for Tonic-Clonic Seizures, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tonic-Clonic Seizures. This report contains market size and forecasts of Tonic-Clonic Seizures in global, including the following market information:
Global Tonic-Clonic Seizures Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Tonic-Clonic Seizures market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
We surveyed the Tonic-Clonic Seizures companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tonic-Clonic Seizures Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Tonic-Clonic Seizures Market Segment Percentages, by Type, 2022 (%)
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others
Global Tonic-Clonic Seizures Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Tonic-Clonic Seizures Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Academic and Research Centers
Others
Global Tonic-Clonic Seizures Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Tonic-Clonic Seizures Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tonic-Clonic Seizures revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tonic-Clonic Seizures revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tonic-Clonic Seizures, market overview.
Chapter 2: Global Tonic-Clonic Seizures market size in revenue.
Chapter 3: Detailed analysis of Tonic-Clonic Seizures company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tonic-Clonic Seizures in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tonic-Clonic Seizures Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tonic-Clonic Seizures Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tonic-Clonic Seizures Overall Market Size
2.1 Global Tonic-Clonic Seizures Market Size: 2022 VS 2030
2.2 Global Tonic-Clonic Seizures Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tonic-Clonic Seizures Players in Global Market
3.2 Top Global Tonic-Clonic Seizures Companies Ranked by Revenue
3.3 Global Tonic-Clonic Seizures Revenue by Companies
3.4 Top 3 and Top 5 Tonic-Clonic Seizures Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tonic-Clonic Seizures Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tonic-Clonic Seizures Players in Global Market
3.6.1 List of Global Tier 1 Tonic-Clonic Seizures Companies
3.6.2 List of Global Tier 2 and Tier 3 Tonic-Clonic Seizures Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tonic-Clonic Seizures Market Size Markets, 2022 & 2030
4.1.2 Barbiturates
4.1.3 Hydantoin
4.1.4 Phenyltriazine
4.1.5 Iminostilbenes
4.1.6 Benzodiazepines
4.1.7 Aliphatic Carboxylic Acid
4.1.8 Others
4.2 By Type - Global Tonic-Clonic Seizures Revenue & Forecasts
4.2.1 By Type - Global Tonic-Clonic Seizures Revenue, 2018-2023
4.2.2 By Type - Global Tonic-Clonic Seizures Revenue, 2024-2030
4.2.3 By Type - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tonic-Clonic Seizures Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Academic and Research Centers
5.1.5 Others
5.2 By Application - Global Tonic-Clonic Seizures Revenue & Forecasts
5.2.1 By Application - Global Tonic-Clonic Seizures Revenue, 2018-2023
5.2.2 By Application - Global Tonic-Clonic Seizures Revenue, 2024-2030
5.2.3 By Application - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Tonic-Clonic Seizures Market Size, 2022 & 2030
6.2 By Region - Global Tonic-Clonic Seizures Revenue & Forecasts
6.2.1 By Region - Global Tonic-Clonic Seizures Revenue, 2018-2023
6.2.2 By Region - Global Tonic-Clonic Seizures Revenue, 2024-2030
6.2.3 By Region - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Tonic-Clonic Seizures Revenue, 2018-2030
6.3.2 US Tonic-Clonic Seizures Market Size, 2018-2030
6.3.3 Canada Tonic-Clonic Seizures Market Size, 2018-2030
6.3.4 Mexico Tonic-Clonic Seizures Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Tonic-Clonic Seizures Revenue, 2018-2030
6.4.2 Germany Tonic-Clonic Seizures Market Size, 2018-2030
6.4.3 France Tonic-Clonic Seizures Market Size, 2018-2030
6.4.4 U.K. Tonic-Clonic Seizures Market Size, 2018-2030
6.4.5 Italy Tonic-Clonic Seizures Market Size, 2018-2030
6.4.6 Russia Tonic-Clonic Seizures Market Size, 2018-2030
6.4.7 Nordic Countries Tonic-Clonic Seizures Market Size, 2018-2030
6.4.8 Benelux Tonic-Clonic Seizures Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Tonic-Clonic Seizures Revenue, 2018-2030
6.5.2 China Tonic-Clonic Seizures Market Size, 2018-2030
6.5.3 Japan Tonic-Clonic Seizures Market Size, 2018-2030
6.5.4 South Korea Tonic-Clonic Seizures Market Size, 2018-2030
6.5.5 Southeast Asia Tonic-Clonic Seizures Market Size, 2018-2030
6.5.6 India Tonic-Clonic Seizures Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Tonic-Clonic Seizures Revenue, 2018-2030
6.6.2 Brazil Tonic-Clonic Seizures Market Size, 2018-2030
6.6.3 Argentina Tonic-Clonic Seizures Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tonic-Clonic Seizures Revenue, 2018-2030
6.7.2 Turkey Tonic-Clonic Seizures Market Size, 2018-2030
6.7.3 Israel Tonic-Clonic Seizures Market Size, 2018-2030
6.7.4 Saudi Arabia Tonic-Clonic Seizures Market Size, 2018-2030
6.7.5 UAE Tonic-Clonic Seizures Market Size, 2018-2030
7 Tonic-Clonic Seizures Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Tonic-Clonic Seizures Major Product Offerings
7.1.4 Pfizer Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Tonic-Clonic Seizures Major Product Offerings
7.2.4 Johnson & Johnson Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 UCB Celltech
7.3.1 UCB Celltech Company Summary
7.3.2 UCB Celltech Business Overview
7.3.3 UCB Celltech Tonic-Clonic Seizures Major Product Offerings
7.3.4 UCB Celltech Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.3.5 UCB Celltech Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Tonic-Clonic Seizures Major Product Offerings
7.4.4 Abbott Laboratories Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Tonic-Clonic Seizures Major Product Offerings
7.5.4 GlaxoSmithKline Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Tonic-Clonic Seizures Major Product Offerings
7.6.4 Novartis Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Tonic-Clonic Seizures Major Product Offerings
7.7.4 Sanofi Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Tonic-Clonic Seizures Major Product Offerings
7.8.4 Takeda Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Company Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Tonic-Clonic Seizures Major Product Offerings
7.9.4 Teva Pharmaceutical Tonic-Clonic Seizures Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tonic-Clonic Seizures Market Opportunities & Trends in Global Market
Table 2. Tonic-Clonic Seizures Market Drivers in Global Market
Table 3. Tonic-Clonic Seizures Market Restraints in Global Market
Table 4. Key Players of Tonic-Clonic Seizures in Global Market
Table 5. Top Tonic-Clonic Seizures Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tonic-Clonic Seizures Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tonic-Clonic Seizures Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tonic-Clonic Seizures Product Type
Table 9. List of Global Tier 1 Tonic-Clonic Seizures Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tonic-Clonic Seizures Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Tonic-Clonic Seizures Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tonic-Clonic Seizures Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tonic-Clonic Seizures Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tonic-Clonic Seizures Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tonic-Clonic Seizures Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tonic-Clonic Seizures Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tonic-Clonic Seizures Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Tonic-Clonic Seizures Product Offerings
Table 32. Pfizer Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Tonic-Clonic Seizures Product Offerings
Table 36. Johnson & Johnson Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. UCB Celltech Company Summary
Table 39. UCB Celltech Tonic-Clonic Seizures Product Offerings
Table 40. UCB Celltech Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 41. UCB Celltech Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Tonic-Clonic Seizures Product Offerings
Table 44. Abbott Laboratories Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Tonic-Clonic Seizures Product Offerings
Table 48. GlaxoSmithKline Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Tonic-Clonic Seizures Product Offerings
Table 52. Novartis Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Tonic-Clonic Seizures Product Offerings
Table 56. Sanofi Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Takeda Company Summary
Table 59. Takeda Tonic-Clonic Seizures Product Offerings
Table 60. Takeda Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Key News & Latest Developments
Table 62. Teva Pharmaceutical Company Summary
Table 63. Teva Pharmaceutical Tonic-Clonic Seizures Product Offerings
Table 64. Teva Pharmaceutical Tonic-Clonic Seizures Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Tonic-Clonic Seizures Segment by Type in 2022
Figure 2. Tonic-Clonic Seizures Segment by Application in 2022
Figure 3. Global Tonic-Clonic Seizures Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tonic-Clonic Seizures Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Tonic-Clonic Seizures Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tonic-Clonic Seizures Revenue in 2022
Figure 8. By Type - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 9. By Application - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 10. By Type - Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 12. By Application - Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 14. By Region - Global Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 15. By Country - North America Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 16. US Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 20. Germany Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 21. France Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 28. China Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 32. India Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 34. Brazil Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Tonic-Clonic Seizures Revenue Market Share, 2018-2030
Figure 37. Turkey Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Tonic-Clonic Seizures Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. UCB Celltech Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Laboratories Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
